BOSTON ( TheStreet) -- "Sell in May and go away" is an old-school investment aphorism that just won't die.It means the best strategy for avoiding the stock market's summer doldrums is to park your portfolio in Treasury bills or cash until October.
Here are Wednesday's top research calls, including upgrades for Abbott Labs and NetApp, and downgrades for Garmin and Nordsom.
Abbott Laboratories (ABT) has great growth prospects and has paid increasing dividends for more than 40 years. Here's why this Dividend Aristocrat should be in your investment portfolio.
Abbott Laboratories (ABT) said Alere (ALR) hasn't disclosed key information, making the company question whether its proposed $5.8 billion deal will close.